- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07950397
Flourishing for Peace
Flourishing for Peace Curriculum (Currículo de Florecimiento Para la Paz)
This study is a six-arm individually randomized group-treated (IRGT) trial comparing five16-week standalone flourishing curricula conditions with a control condition consisting of the regular curriculum. Participants will be individually randomized to one of the six conditions. Self-report variables and heart rate variability (HRV) data will be assessed at four time points: T1 (baseline, before the curriculum begins), T2 (8-week midterm), T3 (16-week, at the end of the curriculum), and T4 (beginning of next term), with the main outcome testing changes between T1 and T3. Primary outcomes include the lnRMSSD as a measure of HRV and the overall self-reported flourishing score. Secondary outcomes include 20 domain specific psychological scales and two other HRV measures (SDNN, and mean heart rate). Course-specific knowledge tests will also be administered to gauge participant engagement and course effectiveness. Study results will be reported in accordance with the Consolidated Standards of Reporting Trials (CONSORT) guidelines for non-pharmacological interventions.
Descripción general del estudio
Estado
Condiciones
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Andrea Ortega Bechara
- Número de teléfono: +573107286975
- Correo electrónico: a.ortega.bechara@unisinu.edu.co
Ubicaciones de estudio
-
-
-
Montería, Colombia
- Universidad del Sinú (Unisinú)
-
Contacto:
- Andrea Ortega Bechara
- Número de teléfono: +573107286975
- Correo electrónico: a.ortega.bechara@unisinu.edu.co
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- (a) enrollment as a university student at UniSinu; (b) intention to remain in the campus area for at least 12 months and express a commitment to try to remain engaged in the study from beginning to end; and (c) ability to read, speak, and understand Spanish.
Exclusion Criteria:
- No
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Ciencia básica
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Triple
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Resilience and Self-Control
This flourishing curriculum is delivered as a stand-alone, 16-week classroom seminar incorporating lectures, experiential activities, and structured discussions. The content of this curriculum was developed by subject-matter experts. |
Resilience and Self-Control |
|
Experimental: Stress, Coping, and Forgiveness
This flourishing curriculum is delivered as a stand-alone, 16-week classroom seminar incorporating lectures, experiential activities, and structured discussions. The content of this curriculum was developed by subject-matter experts. |
Stress, Coping, and Forgiveness |
|
Experimental: Mindfulness and Meaning and Purpose
This flourishing curriculum combines two courses, and is delivered as a stand-alone, 16-week classroom seminar. Mindfulness will be taught in 8 of the 16 weeks and Meaning and Purpose will be taught in another 8 weeks. Contents incorporate lectures, experiential activities, and structured discussions. The content of this curriculum was developed by subject-matter experts. |
Mindfulness and Meaning and Purpose |
|
Experimental: Quality of Relationships for Peace and Positive Emotions
This flourishing curriculum combines two courses, and is delivered as a stand-alone, 16-week classroom seminar. Quality of Relationships for Peace will be taught in 8 of the 16 weeks and Positive Emotions will be taught in another 8 weeks. Contents incorporate lectures, experiential activities, and structured discussions. The content of this curriculum was developed by subject-matter experts. |
Quality of Relationships for Peace and Positive Emotions |
|
Experimental: Emotional Intelligence, Forgiveness, and Spirituality
This flourishing curriculum is delivered as a stand-alone, 16-week classroom seminar incorporating lectures, experiential activities, and structured discussions. The content of this curriculum was developed by subject-matter experts. |
Emotional Intelligence, Forgiveness, and Spirituality |
|
Comparador activo: Regular course
Participants assigned to the control condition will continue with their regular university coursework but complete the same measures as the intervention conditions. |
Regular course |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Overall Flourishing: Flourish Measure
Periodo de tiempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Use the total score across 10 items of the Flourish measure developed by Tyler VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
lnRMSSD
Periodo de tiempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Heart rate variability (HRV) will be collected using a validated chest-strap sensor ( the Polar H10; Polar Electro, Kempele, Finland) during standardized resting assessments. The natural logarithm of the root mean square of successive differences between normal RR intervals (lnRMSSD), a time-domain measure of short-term heart rate variability and vagal/parasympathetic regulation, will be used as the primary HRV outcome. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Happiness and Life Satisfaction: subscale of Flourish Measure
Periodo de tiempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
subscale of the Flourish measure of the primary outcome developed by VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Mental and Physical Health: subscale of Flourish Measure
Periodo de tiempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
subscale of the Flourish measure of the primary outcome developed by VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Meaning and Purpose: subscale of Flourish Measure
Periodo de tiempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
subscale of the Flourish measure of the primary outcome developed by VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Character and Virtue: subscale of Flourish Measure
Periodo de tiempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
subscale of the Flourish measure of the primary outcome developed by VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Close Social Relationships: subscale of Flourish Measure
Periodo de tiempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
subscale of the Flourish measure of the primary outcome developed by VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Depression symptoms: Patient Health Questionnaire-9 (PHQ-9)
Periodo de tiempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 0 to 3. Higher score indicates more severe depressive symptoms. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Anxiety Symptoms: Generalized Anxiety Disorder-7 (GAD-7)
Periodo de tiempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 0 to 3. Higher scores more severe anxiety symptoms. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
The Short Stress Overload Scale
Periodo de tiempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 1 to 5. Higher score indicates higher stress. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Coherence: subscale of the Three Dimensional Meaning in Life Scale (3DM)
Periodo de tiempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 1 to 7. Higher score indicates higher meaning. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Purpose: subscale of the Three Dimensional Meaning in Life Scale (3DM)
Periodo de tiempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 1 to 7. Higher score indicates higher meaning. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Significance: subscale of the Three Dimensional Meaning in Life Scale (3DM)
Periodo de tiempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 1 to 7. Higher score indicates higher meaning. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Trait Forgivingness Scale
Periodo de tiempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 1 to 5. Higher score indicates higher forgiveness. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Trait Humility: subscale of Relational Humility Scale
Periodo de tiempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 1 to 5. Higher score indicates higher humility. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Cognitive and Affective Mindfulness Scale-Revised (CAMS-R)
Periodo de tiempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 1 to 4. Higher score indicates higher mindfulness. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Brief Self-Control Scale
Periodo de tiempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 1 to 5. Higher score indicates higher self-control |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Brief Resilience Scale
Periodo de tiempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 1 to 5. Higher score indicates higher resilience. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Loneliness: NIH Toolbox Adult Social Relationship Scales
Periodo de tiempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 1 to 5. Higher score indicates higher level of loneliness |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Transcendent Spirituality: subscale of Trait Sources of Spirituality Scale
Periodo de tiempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 1 to 5. Higher score indicates higher level of spirituality |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Persevering Hope Scale
Periodo de tiempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 1 to 5. Higher score indicates higher level of hope |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Coping Self-Efficacy Scale
Periodo de tiempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 0 to 10. Higher score indicates higher level of self-efficacy |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
SDNN
Periodo de tiempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Standard Deviation of Normal-to-Normal intervals, another HRV measure |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Mean Heart Rate
Periodo de tiempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Mean Heart Rate |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- Acta No. 005 de 2025
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .